most common side effects are headache and gastrointestinal disturbances
the long-term safety of these drugs has yet to be established
zafirlukast may cause raised transaminases. Rarely, liver function tests were consistent with drug-induced hepatitis which resolved on withdrawal of the drug. Zafirlukast should not be used in patients with cirrhosis or liver impairment
Churg-Strauss syndrome has occurred in patients taking zafirlukast and montelukast. In most of these cases the onset of the condition was associated with withdrawal of oral steroids and it is unclear whether the Churg-Strauss syndrome was a direct result of leukotriene antagonist therapy
in elderly patients taking zafirlukast, an increased incidence of respiratory tract infections has been noted. In children taking montelukast pharyngitis, sinusitis and influenza were more common than in patients taking placebo. Similarly in adults, influenza was more common in patients taking montelukast than placebo
Reference:
Ng J, Savage R, McQueen F. Churg-Strauss vasculitis syndrome and leukotriene receptor antagonists. . Ann Rheum Dis. 2005 Sep;64(9):1382
Wooltorton E.Asthma drug zafirlukast (Accolate): serious hepatic events. CMAJ. 2004 May 25;170(11):1668
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.